Our Team

Our Team

STEERING COMMITTEE

Dr. Claude Perreault, M.D., F.C.A.H.S., Executive Chairman and Lead PI, Genome Canada - Personalized Cancer ImmunoTherapy Program; Principal Investigator, Immunobiology Research Unit, IRIC; Professor, Department of Medicine, Université de Montréal; Hematologist, Hôpital Maisonneuve-Rosemont

Dr. Denis-Claude Roy, M.D., FRCPC, Vice Chairman and Co- PI, Genome Canada - Personalized Cancer ImmunoTherapy Program; Director, Cellular Therapy Laboratory, Scientific Director, Hôpital Maisonneuve-Rosemont Research Center; Professor, Department of Medicine, Université de Montréal

Dr. Marc Lussier, Ph.D., Executive Director, Genome Canada – Personalized Cancer ImmunoTherapy Program; Director of Business Development, Center of Excellence in Cell Therapy, Hôpital Maisonneuve-Rosemont

Dr. Silvy Lachance, M.D., FRCPC, Director, Stem Cell Transplant Program, Director, Fellowship Program in Stem Cell Transplantation, Hôpital Maisonneuve-Rosemont/Université de Montréal; Clinician Researcher, Hematology Division, Hematologist, Hôpital Maisonneuve-Rosemont; Associate Professor of Medicine, Université de Montréal; Past President, Canadian Blood and Marrow Transplant Group

Dr. Lambert Busque, M.D. FRCPC, Professor, Department of Medicine, Université de Montréal; Hematologist, Clinician Researcher, Medical Head, Program of Medical Biology, Medical Head, Molecular Diagnostic Laboratory, Hôpital Maisonneuve-Rosemont